We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Quantification of Upper Extremity Hypertonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00285870
Recruitment Status : Completed
First Posted : February 2, 2006
Last Update Posted : March 12, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Dr. Sanger and the research team want to learn about upper extremity hypertonia (stiffness) in children and young adults with cerebral palsy. Specifically, they want to learn about ways to measure the stiffness in the joints of hypertonic arms. The information the research team will collect includes any physical exams or computer generated data about your arm movements.

Condition or disease Phase
Dystonia Muscle Hypertonia Phase 1 Phase 2

Study Design

Study Type : Observational
Actual Enrollment : 60 participants
Time Perspective: Prospective
Official Title: Quantification of Upper Extremity Hypertonia
Study Start Date : January 2006
Primary Completion Date : December 2012
Study Completion Date : December 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Observation [ Time Frame: 1 hour ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Children with cerebral palsy and/or dystonia.
Criteria

Inclusion Criteria:Dystonia in at least one arm Age 4 to no upper limit

Exclusion Criteria:increased risk of participation botulinum toxin within 6 months

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00285870


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
University of Southern California
Investigators
Principal Investigator: Terence D. Sanger Stanford University
More Information

Responsible Party: Terence Sanger, Associate Professor, University of Southern California
ClinicalTrials.gov Identifier: NCT00285870     History of Changes
Other Study ID Numbers: UPPER EXTREMITY HYPERTONIA
First Posted: February 2, 2006    Key Record Dates
Last Update Posted: March 12, 2013
Last Verified: March 2013

Additional relevant MeSH terms:
Dystonia
Muscle Hypertonia
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Neuromuscular Manifestations